
Medicine and Health
Structural basis for modulation of human Nav1.3 by clinical drug and selective antagonist
X. Li, F. Xu, et al.
Dive into the fascinating world of voltage-gated sodium channels! This study reveals how NaV1.3 interacts with specific modulators like bulleyaconitine A and ICA121431, shedding light on their unique binding mechanisms. Conducted by esteemed researchers including Xiaojing Li and Feng Xu, these findings are paving the way for targeted therapeutic advancements.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.